Melanie Desbois
Villejuif, 94805, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
IGM-7354, an Immunocytokine with IL15 Fused to an Anti-PD-L1 IgM, Induces NK and CD8+ T cell-Mediated Cytotoxicity of PD-L1-Positive Tumor Cells.
Journal: Cancer immunology research
Published: October 02, 2024
Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment.
Journal: Immunological reviews
Published: March 01, 2021
Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects.
Journal: Journal for immunotherapy of cancer
Published: June 16, 2020
IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment.
Journal: Journal for immunotherapy of cancer
Published: April 07, 2020
Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer.
Journal: Nature communications
Published: October 04, 2019
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer.
Journal: Nature communications
Published: April 04, 2019
IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 05, 2016
Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
Journal: Cell research
Published: March 04, 2015
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
Journal: Cell research
Published: May 22, 2014
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors.
Journal: Cancer research
Published: April 18, 2013
Last Updated: 09/26/2026